nodes	percent_of_prediction	percent_of_DWPC	metapath
Clopidogrel—ABCB1—Methylprednisolone—multiple sclerosis	0.0509	0.0864	CbGbCtD
Clopidogrel—CYP3A4—Fingolimod—multiple sclerosis	0.0473	0.0803	CbGbCtD
Clopidogrel—CYP2C19—Prednisone—multiple sclerosis	0.0382	0.0648	CbGbCtD
Clopidogrel—CYP2B6—Dexamethasone—multiple sclerosis	0.0375	0.0637	CbGbCtD
Clopidogrel—ABCB1—Mitoxantrone—multiple sclerosis	0.0371	0.063	CbGbCtD
Clopidogrel—ABCB1—Betamethasone—multiple sclerosis	0.0331	0.0561	CbGbCtD
Clopidogrel—ABCB1—Prednisolone—multiple sclerosis	0.0326	0.0554	CbGbCtD
Clopidogrel—ABCB1—Prednisone—multiple sclerosis	0.0308	0.0523	CbGbCtD
Clopidogrel—CYP3A4—Methylprednisolone—multiple sclerosis	0.0305	0.0517	CbGbCtD
Clopidogrel—CYP3A5—Dexamethasone—multiple sclerosis	0.0296	0.0502	CbGbCtD
Clopidogrel—CYP2C8—Dexamethasone—multiple sclerosis	0.0284	0.0482	CbGbCtD
Clopidogrel—CYP2C19—Dexamethasone—multiple sclerosis	0.0238	0.0405	CbGbCtD
Clopidogrel—CYP3A4—Triamcinolone—multiple sclerosis	0.0231	0.0392	CbGbCtD
Clopidogrel—CYP3A4—Mitoxantrone—multiple sclerosis	0.0222	0.0377	CbGbCtD
Clopidogrel—CYP2C9—Dexamethasone—multiple sclerosis	0.0198	0.0337	CbGbCtD
Clopidogrel—CYP3A4—Betamethasone—multiple sclerosis	0.0198	0.0336	CbGbCtD
Clopidogrel—CYP3A4—Prednisolone—multiple sclerosis	0.0196	0.0332	CbGbCtD
Clopidogrel—ABCB1—Dexamethasone—multiple sclerosis	0.0192	0.0327	CbGbCtD
Clopidogrel—CYP3A4—Prednisone—multiple sclerosis	0.0185	0.0313	CbGbCtD
Clopidogrel—ABCB1—Methotrexate—multiple sclerosis	0.0155	0.0262	CbGbCtD
Clopidogrel—CYP3A4—Dexamethasone—multiple sclerosis	0.0115	0.0196	CbGbCtD
Clopidogrel—Prasugrel—ALB—multiple sclerosis	0.00239	1	CrCbGaD
Clopidogrel—Myalgia—Triamcinolone—multiple sclerosis	0.00021	0.000671	CcSEcCtD
Clopidogrel—Vomiting—Azathioprine—multiple sclerosis	0.00021	0.000671	CcSEcCtD
Clopidogrel—Pneumonia—Methotrexate—multiple sclerosis	0.000209	0.00067	CcSEcCtD
Clopidogrel—Myalgia—Methylprednisolone—multiple sclerosis	0.000209	0.00067	CcSEcCtD
Clopidogrel—Arthralgia—Methylprednisolone—multiple sclerosis	0.000209	0.00067	CcSEcCtD
Clopidogrel—Eye disorder—Prednisone—multiple sclerosis	0.000209	0.000669	CcSEcCtD
Clopidogrel—Anxiety—Methylprednisolone—multiple sclerosis	0.000208	0.000668	CcSEcCtD
Clopidogrel—Rash—Azathioprine—multiple sclerosis	0.000208	0.000665	CcSEcCtD
Clopidogrel—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000208	0.000665	CcSEcCtD
Clopidogrel—Dermatitis—Azathioprine—multiple sclerosis	0.000208	0.000665	CcSEcCtD
Clopidogrel—Depression—Methotrexate—multiple sclerosis	0.000208	0.000665	CcSEcCtD
Clopidogrel—Headache—Azathioprine—multiple sclerosis	0.000206	0.000661	CcSEcCtD
Clopidogrel—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000206	0.000661	CcSEcCtD
Clopidogrel—Renal failure—Methotrexate—multiple sclerosis	0.000205	0.000655	CcSEcCtD
Clopidogrel—Angioedema—Dexamethasone—multiple sclerosis	0.000204	0.000654	CcSEcCtD
Clopidogrel—Angioedema—Betamethasone—multiple sclerosis	0.000204	0.000654	CcSEcCtD
Clopidogrel—Stomatitis—Methotrexate—multiple sclerosis	0.000203	0.00065	CcSEcCtD
Clopidogrel—Angiopathy—Prednisone—multiple sclerosis	0.000203	0.00065	CcSEcCtD
Clopidogrel—Conjunctivitis—Methotrexate—multiple sclerosis	0.000202	0.000648	CcSEcCtD
Clopidogrel—Confusional state—Methylprednisolone—multiple sclerosis	0.000202	0.000648	CcSEcCtD
Clopidogrel—Immune system disorder—Prednisone—multiple sclerosis	0.000202	0.000647	CcSEcCtD
Clopidogrel—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000201	0.000644	CcSEcCtD
Clopidogrel—Oedema—Triamcinolone—multiple sclerosis	0.000201	0.000644	CcSEcCtD
Clopidogrel—Vertigo—Dexamethasone—multiple sclerosis	0.000201	0.000643	CcSEcCtD
Clopidogrel—Vertigo—Betamethasone—multiple sclerosis	0.000201	0.000643	CcSEcCtD
Clopidogrel—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000201	0.000642	CcSEcCtD
Clopidogrel—Syncope—Dexamethasone—multiple sclerosis	0.0002	0.000642	CcSEcCtD
Clopidogrel—Syncope—Betamethasone—multiple sclerosis	0.0002	0.000642	CcSEcCtD
Clopidogrel—Infection—Triamcinolone—multiple sclerosis	0.0002	0.000639	CcSEcCtD
Clopidogrel—Infection—Methylprednisolone—multiple sclerosis	0.000199	0.000638	CcSEcCtD
Clopidogrel—Haematuria—Methotrexate—multiple sclerosis	0.000198	0.000635	CcSEcCtD
Clopidogrel—Shock—Triamcinolone—multiple sclerosis	0.000198	0.000633	CcSEcCtD
Clopidogrel—Insomnia—Prednisolone—multiple sclerosis	0.000198	0.000633	CcSEcCtD
Clopidogrel—Shock—Methylprednisolone—multiple sclerosis	0.000197	0.000632	CcSEcCtD
Clopidogrel—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000197	0.00063	CcSEcCtD
Clopidogrel—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000197	0.00063	CcSEcCtD
Clopidogrel—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000196	0.000629	CcSEcCtD
Clopidogrel—Loss of consciousness—Betamethasone—multiple sclerosis	0.000196	0.000629	CcSEcCtD
Clopidogrel—Epistaxis—Methotrexate—multiple sclerosis	0.000196	0.000629	CcSEcCtD
Clopidogrel—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000196	0.000629	CcSEcCtD
Clopidogrel—Paraesthesia—Prednisolone—multiple sclerosis	0.000196	0.000629	CcSEcCtD
Clopidogrel—Mental disorder—Prednisone—multiple sclerosis	0.000196	0.000627	CcSEcCtD
Clopidogrel—Nausea—Azathioprine—multiple sclerosis	0.000196	0.000627	CcSEcCtD
Clopidogrel—Skin disorder—Methylprednisolone—multiple sclerosis	0.000195	0.000624	CcSEcCtD
Clopidogrel—Malnutrition—Prednisone—multiple sclerosis	0.000195	0.000623	CcSEcCtD
Clopidogrel—Agranulocytosis—Methotrexate—multiple sclerosis	0.000194	0.000622	CcSEcCtD
Clopidogrel—Hypertension—Dexamethasone—multiple sclerosis	0.000193	0.000618	CcSEcCtD
Clopidogrel—Hypertension—Betamethasone—multiple sclerosis	0.000193	0.000618	CcSEcCtD
Clopidogrel—Asthenia—Mitoxantrone—multiple sclerosis	0.000191	0.000612	CcSEcCtD
Clopidogrel—Myalgia—Betamethasone—multiple sclerosis	0.00019	0.000609	CcSEcCtD
Clopidogrel—Myalgia—Dexamethasone—multiple sclerosis	0.00019	0.000609	CcSEcCtD
Clopidogrel—Anxiety—Dexamethasone—multiple sclerosis	0.00019	0.000607	CcSEcCtD
Clopidogrel—Anxiety—Betamethasone—multiple sclerosis	0.00019	0.000607	CcSEcCtD
Clopidogrel—Haemoglobin—Methotrexate—multiple sclerosis	0.000188	0.000601	CcSEcCtD
Clopidogrel—Hypotension—Methylprednisolone—multiple sclerosis	0.000187	0.0006	CcSEcCtD
Clopidogrel—Pain—Prednisolone—multiple sclerosis	0.000187	0.000599	CcSEcCtD
Clopidogrel—Haemorrhage—Methotrexate—multiple sclerosis	0.000187	0.000598	CcSEcCtD
Clopidogrel—Hepatitis—Methotrexate—multiple sclerosis	0.000187	0.000598	CcSEcCtD
Clopidogrel—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000185	0.00192	CbGpPWpGaD
Clopidogrel—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000184	0.000591	CcSEcCtD
Clopidogrel—P2RY12—Signaling Pathways—LINGO1—multiple sclerosis	0.000184	0.00191	CbGpPWpGaD
Clopidogrel—Urethral disorder—Methotrexate—multiple sclerosis	0.000183	0.000586	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000183	0.000586	CcSEcCtD
Clopidogrel—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	0.000183	0.0019	CbGpPWpGaD
Clopidogrel—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000183	0.000585	CcSEcCtD
Clopidogrel—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000182	0.000584	CcSEcCtD
Clopidogrel—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000182	0.000584	CcSEcCtD
Clopidogrel—Oedema—Dexamethasone—multiple sclerosis	0.000182	0.000584	CcSEcCtD
Clopidogrel—Oedema—Betamethasone—multiple sclerosis	0.000182	0.000584	CcSEcCtD
Clopidogrel—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000182	0.000584	CcSEcCtD
Clopidogrel—Insomnia—Triamcinolone—multiple sclerosis	0.000182	0.000582	CcSEcCtD
Clopidogrel—P2RY12—G alpha (i) signalling events—POMC—multiple sclerosis	0.000182	0.00189	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—ITGA4—multiple sclerosis	0.000181	0.00189	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR ligand binding—CXCL10—multiple sclerosis	0.000181	0.00188	CbGpPWpGaD
Clopidogrel—Insomnia—Methylprednisolone—multiple sclerosis	0.000181	0.000581	CcSEcCtD
Clopidogrel—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	0.000181	0.00188	CbGpPWpGaD
Clopidogrel—Infection—Betamethasone—multiple sclerosis	0.000181	0.00058	CcSEcCtD
Clopidogrel—Infection—Dexamethasone—multiple sclerosis	0.000181	0.00058	CcSEcCtD
Clopidogrel—Paraesthesia—Triamcinolone—multiple sclerosis	0.00018	0.000578	CcSEcCtD
Clopidogrel—P2RY12—Hemostasis—IFNB1—multiple sclerosis	0.00018	0.00187	CbGpPWpGaD
Clopidogrel—Feeling abnormal—Prednisolone—multiple sclerosis	0.00018	0.000577	CcSEcCtD
Clopidogrel—Paraesthesia—Methylprednisolone—multiple sclerosis	0.00018	0.000577	CcSEcCtD
Clopidogrel—Visual impairment—Methotrexate—multiple sclerosis	0.00018	0.000577	CcSEcCtD
Clopidogrel—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	0.00018	0.00187	CbGpPWpGaD
Clopidogrel—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	0.00018	0.00187	CbGpPWpGaD
Clopidogrel—Anaemia—Prednisone—multiple sclerosis	0.00018	0.000576	CcSEcCtD
Clopidogrel—Shock—Betamethasone—multiple sclerosis	0.000179	0.000575	CcSEcCtD
Clopidogrel—Shock—Dexamethasone—multiple sclerosis	0.000179	0.000575	CcSEcCtD
Clopidogrel—Dyspnoea—Triamcinolone—multiple sclerosis	0.000179	0.000574	CcSEcCtD
Clopidogrel—Nervous system disorder—Betamethasone—multiple sclerosis	0.000179	0.000573	CcSEcCtD
Clopidogrel—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000179	0.000573	CcSEcCtD
Clopidogrel—Angioedema—Prednisone—multiple sclerosis	0.000178	0.000569	CcSEcCtD
Clopidogrel—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000177	0.00184	CbGpPWpGaD
Clopidogrel—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000177	0.00184	CbGpPWpGaD
Clopidogrel—Dyspepsia—Triamcinolone—multiple sclerosis	0.000177	0.000567	CcSEcCtD
Clopidogrel—Erythema multiforme—Methotrexate—multiple sclerosis	0.000177	0.000566	CcSEcCtD
Clopidogrel—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000177	0.000565	CcSEcCtD
Clopidogrel—Vertigo—Prednisone—multiple sclerosis	0.000175	0.00056	CcSEcCtD
Clopidogrel—Eye disorder—Methotrexate—multiple sclerosis	0.000175	0.000559	CcSEcCtD
Clopidogrel—Syncope—Prednisone—multiple sclerosis	0.000175	0.000559	CcSEcCtD
Clopidogrel—ABCB1—Allograft Rejection—CD40—multiple sclerosis	0.000174	0.00181	CbGpPWpGaD
Clopidogrel—Tinnitus—Methotrexate—multiple sclerosis	0.000174	0.000558	CcSEcCtD
Clopidogrel—P2RY12—Platelet activation, signaling and aggregation—ALB—multiple sclerosis	0.000174	0.00181	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—CCR1—multiple sclerosis	0.000174	0.00181	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—CXCL13—multiple sclerosis	0.000174	0.00181	CbGpPWpGaD
Clopidogrel—Urticaria—Prednisolone—multiple sclerosis	0.000174	0.000556	CcSEcCtD
Clopidogrel—Fatigue—Triamcinolone—multiple sclerosis	0.000173	0.000555	CcSEcCtD
Clopidogrel—Fatigue—Methylprednisolone—multiple sclerosis	0.000173	0.000554	CcSEcCtD
Clopidogrel—Pain—Triamcinolone—multiple sclerosis	0.000172	0.00055	CcSEcCtD
Clopidogrel—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	0.000172	0.00179	CbGpPWpGaD
Clopidogrel—Loss of consciousness—Prednisone—multiple sclerosis	0.000171	0.000548	CcSEcCtD
Clopidogrel—Hypotension—Dexamethasone—multiple sclerosis	0.00017	0.000546	CcSEcCtD
Clopidogrel—Hypotension—Betamethasone—multiple sclerosis	0.00017	0.000546	CcSEcCtD
Clopidogrel—Angiopathy—Methotrexate—multiple sclerosis	0.000169	0.000543	CcSEcCtD
Clopidogrel—Vomiting—Mitoxantrone—multiple sclerosis	0.000169	0.000542	CcSEcCtD
Clopidogrel—Immune system disorder—Methotrexate—multiple sclerosis	0.000169	0.00054	CcSEcCtD
Clopidogrel—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000168	0.000539	CcSEcCtD
Clopidogrel—Hypertension—Prednisone—multiple sclerosis	0.000168	0.000538	CcSEcCtD
Clopidogrel—Rash—Mitoxantrone—multiple sclerosis	0.000168	0.000538	CcSEcCtD
Clopidogrel—Dermatitis—Mitoxantrone—multiple sclerosis	0.000168	0.000537	CcSEcCtD
Clopidogrel—Headache—Mitoxantrone—multiple sclerosis	0.000167	0.000534	CcSEcCtD
Clopidogrel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000166	0.00173	CbGpPWpGaD
Clopidogrel—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000166	0.000532	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000166	0.000532	CcSEcCtD
Clopidogrel—Myalgia—Prednisone—multiple sclerosis	0.000166	0.000531	CcSEcCtD
Clopidogrel—Arthralgia—Prednisone—multiple sclerosis	0.000166	0.000531	CcSEcCtD
Clopidogrel—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000166	0.00053	CcSEcCtD
Clopidogrel—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000165	0.000529	CcSEcCtD
Clopidogrel—Anxiety—Prednisone—multiple sclerosis	0.000165	0.000529	CcSEcCtD
Clopidogrel—Insomnia—Betamethasone—multiple sclerosis	0.000165	0.000528	CcSEcCtD
Clopidogrel—Insomnia—Dexamethasone—multiple sclerosis	0.000165	0.000528	CcSEcCtD
Clopidogrel—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000165	0.000527	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000164	0.000525	CcSEcCtD
Clopidogrel—Paraesthesia—Dexamethasone—multiple sclerosis	0.000164	0.000524	CcSEcCtD
Clopidogrel—Paraesthesia—Betamethasone—multiple sclerosis	0.000164	0.000524	CcSEcCtD
Clopidogrel—Mental disorder—Methotrexate—multiple sclerosis	0.000164	0.000524	CcSEcCtD
Clopidogrel—Malnutrition—Methotrexate—multiple sclerosis	0.000163	0.000521	CcSEcCtD
Clopidogrel—Hypersensitivity—Prednisolone—multiple sclerosis	0.000161	0.000516	CcSEcCtD
Clopidogrel—Dyspepsia—Dexamethasone—multiple sclerosis	0.000161	0.000514	CcSEcCtD
Clopidogrel—Dyspepsia—Betamethasone—multiple sclerosis	0.000161	0.000514	CcSEcCtD
Clopidogrel—Urticaria—Triamcinolone—multiple sclerosis	0.00016	0.000511	CcSEcCtD
Clopidogrel—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.00016	0.00166	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—TAGAP—multiple sclerosis	0.000159	0.00166	CbGpPWpGaD
Clopidogrel—Urticaria—Methylprednisolone—multiple sclerosis	0.000159	0.00051	CcSEcCtD
Clopidogrel—Body temperature increased—Triamcinolone—multiple sclerosis	0.000159	0.000509	CcSEcCtD
Clopidogrel—Anaphylactic shock—Prednisone—multiple sclerosis	0.000159	0.000509	CcSEcCtD
Clopidogrel—Oedema—Prednisone—multiple sclerosis	0.000159	0.000509	CcSEcCtD
Clopidogrel—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000159	0.000508	CcSEcCtD
Clopidogrel—Nausea—Mitoxantrone—multiple sclerosis	0.000158	0.000507	CcSEcCtD
Clopidogrel—Infection—Prednisone—multiple sclerosis	0.000158	0.000505	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000157	0.000504	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000157	0.000504	CcSEcCtD
Clopidogrel—Back pain—Methotrexate—multiple sclerosis	0.000157	0.000504	CcSEcCtD
Clopidogrel—Fatigue—Dexamethasone—multiple sclerosis	0.000157	0.000504	CcSEcCtD
Clopidogrel—Fatigue—Betamethasone—multiple sclerosis	0.000157	0.000504	CcSEcCtD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000157	0.00163	CbGpPWpGaD
Clopidogrel—Shock—Prednisone—multiple sclerosis	0.000156	0.0005	CcSEcCtD
Clopidogrel—P2RY12—GPCR ligand binding—CCL5—multiple sclerosis	0.000156	0.00162	CbGpPWpGaD
Clopidogrel—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000156	0.00162	CbGpPWpGaD
Clopidogrel—Pain—Dexamethasone—multiple sclerosis	0.000156	0.000499	CcSEcCtD
Clopidogrel—Pain—Betamethasone—multiple sclerosis	0.000156	0.000499	CcSEcCtD
Clopidogrel—Nervous system disorder—Prednisone—multiple sclerosis	0.000156	0.000499	CcSEcCtD
Clopidogrel—CES1—NRF2 pathway—TGFB1—multiple sclerosis	0.000156	0.00162	CbGpPWpGaD
Clopidogrel—Skin disorder—Prednisone—multiple sclerosis	0.000154	0.000494	CcSEcCtD
Clopidogrel—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	0.000151	0.00157	CbGpPWpGaD
Clopidogrel—Anaemia—Methotrexate—multiple sclerosis	0.00015	0.000481	CcSEcCtD
Clopidogrel—Feeling abnormal—Betamethasone—multiple sclerosis	0.00015	0.000481	CcSEcCtD
Clopidogrel—Feeling abnormal—Dexamethasone—multiple sclerosis	0.00015	0.000481	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000149	0.000478	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000149	0.000478	CcSEcCtD
Clopidogrel—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000148	0.000474	CcSEcCtD
Clopidogrel—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000148	0.000473	CcSEcCtD
Clopidogrel—Vertigo—Methotrexate—multiple sclerosis	0.000146	0.000468	CcSEcCtD
Clopidogrel—Leukopenia—Methotrexate—multiple sclerosis	0.000146	0.000466	CcSEcCtD
Clopidogrel—Urticaria—Dexamethasone—multiple sclerosis	0.000145	0.000464	CcSEcCtD
Clopidogrel—Urticaria—Betamethasone—multiple sclerosis	0.000145	0.000464	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000145	0.000463	CcSEcCtD
Clopidogrel—Dizziness—Prednisolone—multiple sclerosis	0.000145	0.000463	CcSEcCtD
Clopidogrel—P2RY12—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000144	0.0015	CbGpPWpGaD
Clopidogrel—Asthenia—Triamcinolone—multiple sclerosis	0.000144	0.000462	CcSEcCtD
Clopidogrel—Abdominal pain—Betamethasone—multiple sclerosis	0.000144	0.000462	CcSEcCtD
Clopidogrel—Abdominal pain—Dexamethasone—multiple sclerosis	0.000144	0.000462	CcSEcCtD
Clopidogrel—Body temperature increased—Betamethasone—multiple sclerosis	0.000144	0.000462	CcSEcCtD
Clopidogrel—Body temperature increased—Dexamethasone—multiple sclerosis	0.000144	0.000462	CcSEcCtD
Clopidogrel—Asthenia—Methylprednisolone—multiple sclerosis	0.000144	0.000461	CcSEcCtD
Clopidogrel—Insomnia—Prednisone—multiple sclerosis	0.000144	0.00046	CcSEcCtD
Clopidogrel—Paraesthesia—Prednisone—multiple sclerosis	0.000143	0.000457	CcSEcCtD
Clopidogrel—Pruritus—Triamcinolone—multiple sclerosis	0.000142	0.000455	CcSEcCtD
Clopidogrel—Cough—Methotrexate—multiple sclerosis	0.000142	0.000454	CcSEcCtD
Clopidogrel—Pruritus—Methylprednisolone—multiple sclerosis	0.000142	0.000454	CcSEcCtD
Clopidogrel—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	0.000142	0.00147	CbGpPWpGaD
Clopidogrel—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000141	0.00147	CbGpPWpGaD
Clopidogrel—P2RY12—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	0.000141	0.00146	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR ligand binding—CCR5—multiple sclerosis	0.000141	0.00146	CbGpPWpGaD
Clopidogrel—Dyspepsia—Prednisone—multiple sclerosis	0.00014	0.000448	CcSEcCtD
Clopidogrel—P2RY12—Signaling Pathways—S1PR1—multiple sclerosis	0.000139	0.00145	CbGpPWpGaD
Clopidogrel—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000139	0.00144	CbGpPWpGaD
Clopidogrel—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000139	0.00144	CbGpPWpGaD
Clopidogrel—Arthralgia—Methotrexate—multiple sclerosis	0.000138	0.000443	CcSEcCtD
Clopidogrel—Myalgia—Methotrexate—multiple sclerosis	0.000138	0.000443	CcSEcCtD
Clopidogrel—Chest pain—Methotrexate—multiple sclerosis	0.000138	0.000443	CcSEcCtD
Clopidogrel—Rash—Prednisolone—multiple sclerosis	0.000138	0.000441	CcSEcCtD
Clopidogrel—Dermatitis—Prednisolone—multiple sclerosis	0.000138	0.000441	CcSEcCtD
Clopidogrel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000137	0.00044	CcSEcCtD
Clopidogrel—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000137	0.000439	CcSEcCtD
Clopidogrel—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000137	0.00142	CbGpPWpGaD
Clopidogrel—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000137	0.00142	CbGpPWpGaD
Clopidogrel—Fatigue—Prednisone—multiple sclerosis	0.000137	0.000439	CcSEcCtD
Clopidogrel—Headache—Prednisolone—multiple sclerosis	0.000137	0.000438	CcSEcCtD
Clopidogrel—ABCB1—Allograft Rejection—CD86—multiple sclerosis	0.000136	0.00142	CbGpPWpGaD
Clopidogrel—Constipation—Prednisone—multiple sclerosis	0.000136	0.000435	CcSEcCtD
Clopidogrel—P2RY12—Signaling Pathways—GPC5—multiple sclerosis	0.000136	0.00141	CbGpPWpGaD
Clopidogrel—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000135	0.0014	CbGpPWpGaD
Clopidogrel—Confusional state—Methotrexate—multiple sclerosis	0.000134	0.000429	CcSEcCtD
Clopidogrel—ABCB1—Allograft Rejection—IL10—multiple sclerosis	0.000134	0.00139	CbGpPWpGaD
Clopidogrel—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	0.000134	0.00139	CbGpPWpGaD
Clopidogrel—Dizziness—Triamcinolone—multiple sclerosis	0.000133	0.000426	CcSEcCtD
Clopidogrel—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000133	0.000425	CcSEcCtD
Clopidogrel—Dizziness—Methylprednisolone—multiple sclerosis	0.000133	0.000425	CcSEcCtD
Clopidogrel—Infection—Methotrexate—multiple sclerosis	0.000132	0.000422	CcSEcCtD
Clopidogrel—P2RY12—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000131	0.00136	CbGpPWpGaD
Clopidogrel—Feeling abnormal—Prednisone—multiple sclerosis	0.000131	0.000419	CcSEcCtD
Clopidogrel—Asthenia—Dexamethasone—multiple sclerosis	0.000131	0.000419	CcSEcCtD
Clopidogrel—Asthenia—Betamethasone—multiple sclerosis	0.000131	0.000419	CcSEcCtD
Clopidogrel—Nervous system disorder—Methotrexate—multiple sclerosis	0.00013	0.000417	CcSEcCtD
Clopidogrel—ABCB1—Allograft Rejection—IL4—multiple sclerosis	0.00013	0.00135	CbGpPWpGaD
Clopidogrel—Gastrointestinal pain—Prednisone—multiple sclerosis	0.00013	0.000416	CcSEcCtD
Clopidogrel—Nausea—Prednisolone—multiple sclerosis	0.00013	0.000416	CcSEcCtD
Clopidogrel—CYP2B6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000129	0.00134	CbGpPWpGaD
Clopidogrel—Pruritus—Dexamethasone—multiple sclerosis	0.000129	0.000413	CcSEcCtD
Clopidogrel—Pruritus—Betamethasone—multiple sclerosis	0.000129	0.000413	CcSEcCtD
Clopidogrel—Skin disorder—Methotrexate—multiple sclerosis	0.000129	0.000413	CcSEcCtD
Clopidogrel—Vomiting—Triamcinolone—multiple sclerosis	0.000128	0.000409	CcSEcCtD
Clopidogrel—Vomiting—Methylprednisolone—multiple sclerosis	0.000128	0.000408	CcSEcCtD
Clopidogrel—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	0.000127	0.00132	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000127	0.00132	CbGpPWpGaD
Clopidogrel—Rash—Triamcinolone—multiple sclerosis	0.000127	0.000406	CcSEcCtD
Clopidogrel—Dermatitis—Triamcinolone—multiple sclerosis	0.000127	0.000405	CcSEcCtD
Clopidogrel—CYP3A5—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000126	0.00131	CbGpPWpGaD
Clopidogrel—Rash—Methylprednisolone—multiple sclerosis	0.000126	0.000405	CcSEcCtD
Clopidogrel—Dermatitis—Methylprednisolone—multiple sclerosis	0.000126	0.000405	CcSEcCtD
Clopidogrel—Urticaria—Prednisone—multiple sclerosis	0.000126	0.000404	CcSEcCtD
Clopidogrel—Headache—Triamcinolone—multiple sclerosis	0.000126	0.000403	CcSEcCtD
Clopidogrel—Headache—Methylprednisolone—multiple sclerosis	0.000126	0.000402	CcSEcCtD
Clopidogrel—Abdominal pain—Prednisone—multiple sclerosis	0.000126	0.000402	CcSEcCtD
Clopidogrel—Body temperature increased—Prednisone—multiple sclerosis	0.000126	0.000402	CcSEcCtD
Clopidogrel—Diarrhoea—Betamethasone—multiple sclerosis	0.000125	0.0004	CcSEcCtD
Clopidogrel—Diarrhoea—Dexamethasone—multiple sclerosis	0.000125	0.0004	CcSEcCtD
Clopidogrel—Hypotension—Methotrexate—multiple sclerosis	0.000124	0.000397	CcSEcCtD
Clopidogrel—P2RY12—Hemostasis—IL2RA—multiple sclerosis	0.000124	0.00129	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—CCL3—multiple sclerosis	0.000124	0.00129	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR downstream signaling—CCR2—multiple sclerosis	0.000123	0.00128	CbGpPWpGaD
Clopidogrel—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000121	0.000387	CcSEcCtD
Clopidogrel—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000121	0.00125	CbGpPWpGaD
Clopidogrel—Dizziness—Dexamethasone—multiple sclerosis	0.000121	0.000386	CcSEcCtD
Clopidogrel—Dizziness—Betamethasone—multiple sclerosis	0.000121	0.000386	CcSEcCtD
Clopidogrel—Insomnia—Methotrexate—multiple sclerosis	0.00012	0.000384	CcSEcCtD
Clopidogrel—ABCB1—Allograft Rejection—FAS—multiple sclerosis	0.00012	0.00124	CbGpPWpGaD
Clopidogrel—Nausea—Triamcinolone—multiple sclerosis	0.000119	0.000382	CcSEcCtD
Clopidogrel—P2RY12—Signaling by GPCR—PTGER4—multiple sclerosis	0.000119	0.00124	CbGpPWpGaD
Clopidogrel—Paraesthesia—Methotrexate—multiple sclerosis	0.000119	0.000382	CcSEcCtD
Clopidogrel—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	0.000119	0.00124	CbGpPWpGaD
Clopidogrel—Nausea—Methylprednisolone—multiple sclerosis	0.000119	0.000381	CcSEcCtD
Clopidogrel—P2RY12—Signaling Pathways—RGS1—multiple sclerosis	0.000118	0.00123	CbGpPWpGaD
Clopidogrel—Dyspnoea—Methotrexate—multiple sclerosis	0.000118	0.000379	CcSEcCtD
Clopidogrel—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	0.000118	0.00122	CbGpPWpGaD
Clopidogrel—Hypersensitivity—Prednisone—multiple sclerosis	0.000117	0.000375	CcSEcCtD
Clopidogrel—Dyspepsia—Methotrexate—multiple sclerosis	0.000117	0.000374	CcSEcCtD
Clopidogrel—Vomiting—Betamethasone—multiple sclerosis	0.000116	0.000371	CcSEcCtD
Clopidogrel—Vomiting—Dexamethasone—multiple sclerosis	0.000116	0.000371	CcSEcCtD
Clopidogrel—P2RY12—Signaling by GPCR—CXCR3—multiple sclerosis	0.000115	0.0012	CbGpPWpGaD
Clopidogrel—Rash—Betamethasone—multiple sclerosis	0.000115	0.000368	CcSEcCtD
Clopidogrel—Rash—Dexamethasone—multiple sclerosis	0.000115	0.000368	CcSEcCtD
Clopidogrel—Dermatitis—Betamethasone—multiple sclerosis	0.000115	0.000368	CcSEcCtD
Clopidogrel—Dermatitis—Dexamethasone—multiple sclerosis	0.000115	0.000368	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000115	0.000367	CcSEcCtD
Clopidogrel—Fatigue—Methotrexate—multiple sclerosis	0.000114	0.000366	CcSEcCtD
Clopidogrel—Headache—Betamethasone—multiple sclerosis	0.000114	0.000366	CcSEcCtD
Clopidogrel—Headache—Dexamethasone—multiple sclerosis	0.000114	0.000366	CcSEcCtD
Clopidogrel—Asthenia—Prednisone—multiple sclerosis	0.000114	0.000365	CcSEcCtD
Clopidogrel—P2RY12—GPCR downstream signaling—CNR1—multiple sclerosis	0.000114	0.00118	CbGpPWpGaD
Clopidogrel—Pain—Methotrexate—multiple sclerosis	0.000113	0.000363	CcSEcCtD
Clopidogrel—Pruritus—Prednisone—multiple sclerosis	0.000112	0.00036	CcSEcCtD
Clopidogrel—P2RY12—Signaling Pathways—GPR65—multiple sclerosis	0.000112	0.00117	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—CCR2—multiple sclerosis	0.000112	0.00116	CbGpPWpGaD
Clopidogrel—P2RY12—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	0.00011	0.00114	CbGpPWpGaD
Clopidogrel—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.00011	0.00114	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR ligand binding—POMC—multiple sclerosis	0.00011	0.00114	CbGpPWpGaD
Clopidogrel—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.00011	0.00114	CbGpPWpGaD
Clopidogrel—Feeling abnormal—Methotrexate—multiple sclerosis	0.000109	0.00035	CcSEcCtD
Clopidogrel—Diarrhoea—Prednisone—multiple sclerosis	0.000109	0.000348	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000109	0.000348	CcSEcCtD
Clopidogrel—Nausea—Dexamethasone—multiple sclerosis	0.000108	0.000347	CcSEcCtD
Clopidogrel—Nausea—Betamethasone—multiple sclerosis	0.000108	0.000347	CcSEcCtD
Clopidogrel—P2RY12—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	0.000108	0.00112	CbGpPWpGaD
Clopidogrel—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	0.000108	0.00112	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR ligand binding—CCL2—multiple sclerosis	0.000108	0.00112	CbGpPWpGaD
Clopidogrel—Urticaria—Methotrexate—multiple sclerosis	0.000105	0.000338	CcSEcCtD
Clopidogrel—Dizziness—Prednisone—multiple sclerosis	0.000105	0.000336	CcSEcCtD
Clopidogrel—Body temperature increased—Methotrexate—multiple sclerosis	0.000105	0.000336	CcSEcCtD
Clopidogrel—Abdominal pain—Methotrexate—multiple sclerosis	0.000105	0.000336	CcSEcCtD
Clopidogrel—P2RY12—Signaling by GPCR—CNR1—multiple sclerosis	0.000103	0.00107	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CCR1—multiple sclerosis	0.000103	0.00107	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CXCL13—multiple sclerosis	0.000103	0.00107	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000103	0.00106	CbGpPWpGaD
Clopidogrel—Vomiting—Prednisone—multiple sclerosis	0.000101	0.000323	CcSEcCtD
Clopidogrel—Rash—Prednisone—multiple sclerosis	0.0001	0.000321	CcSEcCtD
Clopidogrel—Dermatitis—Prednisone—multiple sclerosis	0.0001	0.00032	CcSEcCtD
Clopidogrel—Headache—Prednisone—multiple sclerosis	9.95e-05	0.000319	CcSEcCtD
Clopidogrel—ABCB1—Allograft Rejection—CD80—multiple sclerosis	9.94e-05	0.00103	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	9.93e-05	0.00103	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	9.93e-05	0.00103	CbGpPWpGaD
Clopidogrel—Hypersensitivity—Methotrexate—multiple sclerosis	9.78e-05	0.000313	CcSEcCtD
Clopidogrel—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	9.78e-05	0.00102	CbGpPWpGaD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	9.67e-05	0.001	CbGpPWpGaD
Clopidogrel—Asthenia—Methotrexate—multiple sclerosis	9.52e-05	0.000305	CcSEcCtD
Clopidogrel—Nausea—Prednisone—multiple sclerosis	9.43e-05	0.000302	CcSEcCtD
Clopidogrel—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	9.4e-05	0.000976	CbGpPWpGaD
Clopidogrel—Pruritus—Methotrexate—multiple sclerosis	9.39e-05	0.000301	CcSEcCtD
Clopidogrel—P2RY12—Signaling by GPCR—CXCL10—multiple sclerosis	9.31e-05	0.000967	CbGpPWpGaD
Clopidogrel—Diarrhoea—Methotrexate—multiple sclerosis	9.08e-05	0.000291	CcSEcCtD
Clopidogrel—P2RY12—Hemostasis—ALB—multiple sclerosis	8.96e-05	0.000931	CbGpPWpGaD
Clopidogrel—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	8.91e-05	0.000926	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	8.87e-05	0.000921	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	8.87e-05	0.000921	CbGpPWpGaD
Clopidogrel—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	8.85e-05	0.000919	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR downstream signaling—CCL5—multiple sclerosis	8.82e-05	0.000917	CbGpPWpGaD
Clopidogrel—Dizziness—Methotrexate—multiple sclerosis	8.78e-05	0.000281	CcSEcCtD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	8.63e-05	0.000896	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	8.61e-05	0.000894	CbGpPWpGaD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	8.59e-05	0.000893	CbGpPWpGaD
Clopidogrel—Vomiting—Methotrexate—multiple sclerosis	8.44e-05	0.00027	CcSEcCtD
Clopidogrel—Rash—Methotrexate—multiple sclerosis	8.37e-05	0.000268	CcSEcCtD
Clopidogrel—Dermatitis—Methotrexate—multiple sclerosis	8.36e-05	0.000268	CcSEcCtD
Clopidogrel—Headache—Methotrexate—multiple sclerosis	8.31e-05	0.000266	CcSEcCtD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	8.08e-05	0.00084	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	8.08e-05	0.00084	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—CCL5—multiple sclerosis	8.01e-05	0.000832	CbGpPWpGaD
Clopidogrel—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	8e-05	0.000831	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR downstream signaling—CCR5—multiple sclerosis	7.95e-05	0.000826	CbGpPWpGaD
Clopidogrel—Nausea—Methotrexate—multiple sclerosis	7.88e-05	0.000252	CcSEcCtD
Clopidogrel—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	7.86e-05	0.000816	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR downstream signaling—IL2RA—multiple sclerosis	7.83e-05	0.000814	CbGpPWpGaD
Clopidogrel—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.62e-05	0.000791	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—SRM—multiple sclerosis	7.42e-05	0.00077	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CCL3—multiple sclerosis	7.32e-05	0.00076	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—IL2—multiple sclerosis	7.27e-05	0.000755	CbGpPWpGaD
Clopidogrel—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.25e-05	0.000753	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—SRM—multiple sclerosis	7.25e-05	0.000753	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—CCR5—multiple sclerosis	7.22e-05	0.00075	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—IL2RA—multiple sclerosis	7.11e-05	0.000739	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—PTGER4—multiple sclerosis	7.04e-05	0.000732	CbGpPWpGaD
Clopidogrel—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	7.01e-05	0.000728	CbGpPWpGaD
Clopidogrel—ABCB1—Allograft Rejection—IL2—multiple sclerosis	6.98e-05	0.000725	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—PGR—multiple sclerosis	6.94e-05	0.000721	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	6.91e-05	0.000718	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	6.91e-05	0.000718	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	6.91e-05	0.000718	CbGpPWpGaD
Clopidogrel—CYP2B6—Biological oxidations—POMC—multiple sclerosis	6.87e-05	0.000714	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CXCR3—multiple sclerosis	6.8e-05	0.000707	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CD28—multiple sclerosis	6.74e-05	0.0007	CbGpPWpGaD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	6.72e-05	0.000698	CbGpPWpGaD
Clopidogrel—CYP3A5—Biological oxidations—POMC—multiple sclerosis	6.72e-05	0.000698	CbGpPWpGaD
Clopidogrel—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	6.71e-05	0.000697	CbGpPWpGaD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	6.7e-05	0.000696	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CCR2—multiple sclerosis	6.62e-05	0.000688	CbGpPWpGaD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	6.57e-05	0.000683	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—SRM—multiple sclerosis	6.28e-05	0.000652	CbGpPWpGaD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	6.26e-05	0.00065	CbGpPWpGaD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	6.26e-05	0.00065	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR downstream signaling—POMC—multiple sclerosis	6.21e-05	0.000645	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CNR1—multiple sclerosis	6.11e-05	0.000634	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	5.91e-05	0.000614	CbGpPWpGaD
Clopidogrel—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.88e-05	0.000611	CbGpPWpGaD
Clopidogrel—CYP2C8—Biological oxidations—POMC—multiple sclerosis	5.82e-05	0.000604	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—TGFB1—multiple sclerosis	5.67e-05	0.000589	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—POMC—multiple sclerosis	5.64e-05	0.000586	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—SRM—multiple sclerosis	5.6e-05	0.000582	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—MAPK1—multiple sclerosis	5.56e-05	0.000578	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—CCL2—multiple sclerosis	5.52e-05	0.000573	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CXCL10—multiple sclerosis	5.5e-05	0.000571	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—SRM—multiple sclerosis	5.47e-05	0.000568	CbGpPWpGaD
Clopidogrel—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	5.45e-05	0.000566	CbGpPWpGaD
Clopidogrel—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.3e-05	0.000551	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	5.23e-05	0.000543	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	5.23e-05	0.000543	CbGpPWpGaD
Clopidogrel—CYP2C19—Biological oxidations—POMC—multiple sclerosis	5.19e-05	0.00054	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—SRM—multiple sclerosis	5.11e-05	0.000531	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	5.11e-05	0.000531	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	5.11e-05	0.000531	CbGpPWpGaD
Clopidogrel—ABCB1—Allograft Rejection—TNF—multiple sclerosis	5.09e-05	0.000528	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—TYK2—multiple sclerosis	5.01e-05	0.000521	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CD86—multiple sclerosis	4.81e-05	0.0005	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—GPC5—multiple sclerosis	4.78e-05	0.000496	CbGpPWpGaD
Clopidogrel—CYP2C9—Biological oxidations—POMC—multiple sclerosis	4.74e-05	0.000492	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CCL5—multiple sclerosis	4.73e-05	0.000492	CbGpPWpGaD
Clopidogrel—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.69e-05	0.000487	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—GPC5—multiple sclerosis	4.67e-05	0.000485	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR downstream signaling—IL2—multiple sclerosis	4.59e-05	0.000477	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	4.42e-05	0.00046	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	4.42e-05	0.00046	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—SPP1—multiple sclerosis	4.38e-05	0.000455	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—SRM—multiple sclerosis	4.37e-05	0.000454	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.32e-05	0.000449	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CCR5—multiple sclerosis	4.26e-05	0.000443	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—IL2RA—multiple sclerosis	4.2e-05	0.000437	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—IL2—multiple sclerosis	4.17e-05	0.000433	CbGpPWpGaD
Clopidogrel—CYP1A2—Biological oxidations—POMC—multiple sclerosis	4.05e-05	0.00042	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—GPC5—multiple sclerosis	4.05e-05	0.00042	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—RRM1—multiple sclerosis	3.96e-05	0.000411	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	3.95e-05	0.00041	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	3.95e-05	0.00041	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—APOE—multiple sclerosis	3.88e-05	0.000403	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—RRM1—multiple sclerosis	3.87e-05	0.000402	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.86e-05	0.000401	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—CYP27B1—multiple sclerosis	3.85e-05	0.0004	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—CYP24A1—multiple sclerosis	3.85e-05	0.0004	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—GPC5—multiple sclerosis	3.61e-05	0.000375	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	3.6e-05	0.000374	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	3.6e-05	0.000374	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—GPC5—multiple sclerosis	3.52e-05	0.000366	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.52e-05	0.000366	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CD80—multiple sclerosis	3.51e-05	0.000364	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—SRM—multiple sclerosis	3.37e-05	0.00035	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—RRM1—multiple sclerosis	3.35e-05	0.000348	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—POMC—multiple sclerosis	3.33e-05	0.000346	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—GPC5—multiple sclerosis	3.29e-05	0.000342	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CCL2—multiple sclerosis	3.26e-05	0.000339	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—MAPK1—multiple sclerosis	3.19e-05	0.000331	CbGpPWpGaD
Clopidogrel—CYP3A4—Biological oxidations—POMC—multiple sclerosis	3.12e-05	0.000324	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	3.08e-05	0.00032	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	3.08e-05	0.00032	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.01e-05	0.000312	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—RRM1—multiple sclerosis	2.99e-05	0.000311	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—TYK2—multiple sclerosis	2.96e-05	0.000308	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—RRM1—multiple sclerosis	2.92e-05	0.000303	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—GPC5—multiple sclerosis	2.81e-05	0.000292	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—RRM1—multiple sclerosis	2.73e-05	0.000283	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	2.69e-05	0.00028	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	2.69e-05	0.000279	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	2.64e-05	0.000274	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.6e-05	0.00027	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	2.51e-05	0.000261	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—IL2—multiple sclerosis	2.46e-05	0.000256	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—IL6—multiple sclerosis	2.45e-05	0.000255	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.37e-05	0.000247	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.37e-05	0.000247	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—MMP9—multiple sclerosis	2.33e-05	0.000242	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—RRM1—multiple sclerosis	2.33e-05	0.000242	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.32e-05	0.000241	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—BCHE—multiple sclerosis	2.27e-05	0.000236	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.23e-05	0.000232	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—BCHE—multiple sclerosis	2.22e-05	0.000231	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—GPC5—multiple sclerosis	2.17e-05	0.000226	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.12e-05	0.00022	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—STAT3—multiple sclerosis	2.07e-05	0.000215	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.04e-05	0.000212	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.99e-05	0.000207	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—MYC—multiple sclerosis	1.93e-05	0.0002	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—BCHE—multiple sclerosis	1.93e-05	0.0002	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—TGFB1—multiple sclerosis	1.92e-05	0.0002	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—MAPK1—multiple sclerosis	1.88e-05	0.000196	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.82e-05	0.000189	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.82e-05	0.000189	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.81e-05	0.000188	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.8e-05	0.000187	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.72e-05	0.000179	CbGpPWpGaD
Clopidogrel—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.69e-05	0.000175	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—BCHE—multiple sclerosis	1.68e-05	0.000174	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.66e-05	0.000172	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.57e-05	0.000163	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.55e-05	0.000161	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—IL6—multiple sclerosis	1.45e-05	0.00015	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.42e-05	0.000147	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—APOE—multiple sclerosis	1.37e-05	0.000142	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—BCHE—multiple sclerosis	1.34e-05	0.000139	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—APOE—multiple sclerosis	1.34e-05	0.000139	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—POMC—multiple sclerosis	1.18e-05	0.000122	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—APOE—multiple sclerosis	1.16e-05	0.00012	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—POMC—multiple sclerosis	1.15e-05	0.000119	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—ALB—multiple sclerosis	1.07e-05	0.000111	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—ALB—multiple sclerosis	1.05e-05	0.000109	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—APOE—multiple sclerosis	1.03e-05	0.000107	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.03e-05	0.000107	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—APOE—multiple sclerosis	1.01e-05	0.000105	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—POMC—multiple sclerosis	9.95e-06	0.000103	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—APOE—multiple sclerosis	9.43e-06	9.79e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—ALB—multiple sclerosis	9.07e-06	9.42e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—POMC—multiple sclerosis	8.88e-06	9.23e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—POMC—multiple sclerosis	8.67e-06	9.01e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—POMC—multiple sclerosis	8.1e-06	8.41e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—ALB—multiple sclerosis	8.1e-06	8.41e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—APOE—multiple sclerosis	8.06e-06	8.37e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—ALB—multiple sclerosis	7.9e-06	8.21e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—ALB—multiple sclerosis	7.38e-06	7.67e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—POMC—multiple sclerosis	6.92e-06	7.19e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—ALB—multiple sclerosis	6.31e-06	6.55e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—APOE—multiple sclerosis	6.22e-06	6.46e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—POMC—multiple sclerosis	5.34e-06	5.55e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—ALB—multiple sclerosis	4.87e-06	5.06e-05	CbGpPWpGaD
